Stockreport

Progenity Announces $40 Million Private Placement

Biora Therapeutics, Inc.  (PROG) 
PDF SAN DIEGO, June 10, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered int [Read more]